Skip to main content

Day: February 16, 2024

SmartCentres Declares Distribution for February 2024

TORONTO, Feb. 16, 2024 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”) (TSX: SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of February 2024 of $0.15417 per unit, representing $1.85 per unit on an annualized basis. The distribution will be payable on March 15, 2024 to unitholders of record as at February 29, 2024. About SmartCentres SmartCentres is one of Canada’s largest fully integrated REITs, with a best-in-class and growing mixed-use portfolio featuring 191 strategically located properties in communities across the country. SmartCentres has approximately $11.9 billion in assets and owns 35.0 million square feet of income producing value-oriented retail and first-class office properties with 98.5% in place and committed occupancy, on 3,500 acres...

Continue reading

Arbor Realty Trust Reports Fourth Quarter and Full Year 2023 Results and Declares Dividend of $0.43 per Share

Fourth Quarter Highlights:GAAP net income of $0.48 per diluted common share Distributable earnings1 of $0.51, or $0.54 per diluted common share excluding a $7.0 million realized loss on an office property that was previously reserved for Declares cash dividend on common stock of $0.43 per share representing an annualized dividend of $1.72 per share Strong liquidity position with ~$1 billion in cash and liquidity and ~$600 million of restricted cash in replenishable CLO vehicles with a weighted average cost of 1.74% over SOFR2 Agency loan originations of $1.44 billion and a servicing portfolio of ~$30.98 billion, up 3.5% Structured loan originations of $266.2 million, runoff of $817.4 million, and a portfolio of ~$12.62 billionFull Year Highlights:GAAP net income of $1.75 per diluted common share representing an increase of 5% over...

Continue reading

Global Insurance Analytics Market to Reach Value of USD 29.30 Billion by 2031 | Skyquest Technology

Global insurance analytics market is segmented based on component, deployment, enterprise size, and end use. By component, the market is segmented into solution, and service. By deployment, the market is segmented into on-premise, and cloud. In terms of segmentation by enterprise size, the market is segmented into large, and small & medium enterprise. By end use, the market is segmented into insurance companies, government agencies, third party administrators, brokers & consultancies- Industry forecast 2024-2031 Westford,USA, Feb. 16, 2024 (GLOBE NEWSWIRE) — According to SkyQuest report, the increasing adoption of these [RS1] technologies is primarily driven by the imperative need for their deployment and the provision of integrated and value-added services to clients within the insurance sector. Customers are showing...

Continue reading

Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024

NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter and full year ended December 31, 2023, on Thursday, February 29, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call and webcast with the investment community on Friday, March 1, 2024, at 8:00 a.m. ET. Participating on the call from Y-mAbs will be Michael Rossi, President and Chief Executive Officer; Bo Kruse, Chief Financial Officer; Sue Smith, Chief Commercial Officer; Vignesh Rajah, Chief Medical Officer; Thomas Gad, Founder, Vice Chair and Chief Business Officer; and Steen Lisby, Chief Scientific Officer. Conference call and webcast details:Investors (domestic): (877) 407-0792Investors...

Continue reading

Form 8.3 – Young & Co Brewery Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Young & Co Brewery Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

DT Midstream Reports Strong Fourth Quarter 2023 Results; Raises Dividend and 2024 Adjusted EBITDA Guidance

Full year 2023 Adjusted EBITDA of $924 million represents a 10% increase over the prior year Increased dividend by 7% Increased 2024 Adjusted EBITDA guidance Provided 2025 Adjusted EBITDA early outlookDETROIT, Feb. 16, 2024 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced fourth quarter 2023 reported net income of $121 million, or $1.24 per diluted share. For the fourth quarter of 2023, Operating Earnings were $121 million, or $1.24 per diluted share. Adjusted EBITDA for the quarter was $239 million. Reconciliations of Operating Earnings and Adjusted EBITDA (non-GAAP measures) to reported net income are included at the end of this news release. “As a result of a great team effort, we delivered excellent results in 2023, exceeding our guidance. I want to thank each employee for their contribution,” said David...

Continue reading

Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

MONTVALE, N.J., Feb. 16, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2023 fiscal fourth quarter ended December 31, 2023. The Company reported quarterly net sales of $228.7 million, quarterly net earnings of $26.6 million, adjusted EBITDA(a) of $55.4 million, and free cash flow(a) of $56.0 million. Ted Harris, Chairman, CEO, and President of Balchem said, “The fourth quarter capped off another solid year for Balchem. We delivered record fourth quarter adjusted EBITDA and very strong free cash flow, despite the continued challenging demand environment in parts of our portfolio. I am particularly pleased with our Human Nutrition and Health segment posting record fourth quarter sales and earnings.” Fourth Quarter 2023 Financial Highlights:GAAP net earnings were $26.6 million,...

Continue reading

Pharvaris Announces Extraordinary Meeting of Shareholders

ZUG, Switzerland , Feb. 16, 2024 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the extraordinary general meeting of shareholders will take place on Wednesday, March 6, 2024, at 12:00 CST (6:00 a.m. EST). All relevant documents and information relating to the extraordinary general meeting, including the notice and agenda for the extraordinary general meeting, are or will be made available in the “Investors” section of Pharvaris’ website under “Events & Presentations”. The documents will also be made available on the SEC’s website at www.sec.gov. Shareholders who wish to attend the meeting should register as described in the notice and agenda for the extraordinary general...

Continue reading

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q4 2023

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 22 February 2024 at 13:00 PM (CET) or 14:00 PM (EET). The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com. To join the webinar, please register via the following link:  https://nasdaq.zoom.us/webinar/register/WN_9e5-wNgNQqS6IWUZcs-NHw You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q4 2023

Baltic Horizon Fund invites unitholders, investors, analysts and other stakeholders to join its investor conference webinar, scheduled on 22 February 2024 at 13:00 PM (CET) or 14:00 PM (EET). The webinar will be hosted by Tarmo Karotam, the Fund Manager of Baltic Horizon Fund. Q&A session will follow after the presentation. Due to limited webinar time, we encourage participants to send their questions no later than one day before the webinar to tarmo.karotam@nh-cap.com. To join the webinar, please register via the following link:  https://nasdaq.zoom.us/webinar/register/WN_9e5-wNgNQqS6IWUZcs-NHw You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can’t be downloaded,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.